Abstract
Although total knee arthroplasty (TKA) is highly successful for patients with end-stage rheumatoid arthritis (RA), the risks and complications associated with surgery in this cohort are less defined. The objectives of our study were to analyze the demographic and perioperative factors of RA patients that may affect post-TKA outcomes, as well as to assess the 30-day complication rates compared to osteoarthritis patients. We retrospectively evaluated the National Surgical Quality Improvement Program (NSQIP) database from 2006 to 2012 to assess all patients who underwent a primary TKA and had a diagnosis of rheumatoid arthritis (n = 141) or primary knee osteoarthritis (n = 7125). We evaluated and compared the demographic factors, social factors, preoperative factors, operative factors, and postoperative complications. The RA cohort had a lower mean age and body mass index than patients in the OA group. There was also a significantly higher incidence of women and Hispanics in the RA cohort. There was a lower incidence of diabetes and hypertension requiring medication in the rheumatoid cohort, but also a higher incidence of bleeding disorders. The RA cohort had an increased proportion of patients requiring blood transfusions and had a longer mean length of stay. The incidence of pneumonia and postoperative bleeding that required transfusion was also higher in RA patients. Rheumatoid patients had higher rates of wound infections, pulmonary embolisms, and deep vein thrombosis; however, these findings were not significant. Although RA patients with end-stage knee arthritis may benefit from TKA, these patients should be preoperatively optimized to minimize complication risks.
Similar content being viewed by others
References
Davis JM 3rd, Matteson EL (2012) My treatment approach to rheumatoid arthritis. Mayo Clin Proc 87:659–673
Tanaka E, Saito A, Kamitsuji S, Yamada T, Nakajima A, Taniguchi A et al (2005) Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology Core Data Set. Arthritis Rheum 53(6):864–871
Lee JK, Choi CH (2012) Total knee arthroplasty in rheumatoid arthritis. Knee Surg Relat Res 24:1–6
Healy WL, Della Valle CJ, Iorio R, Berend KR, Cushner FD, Dalury DF et al (2013) Complications of total knee arthroplasty: standardized list and definitions of the Knee Society. Clin Orthop Relat Res 471:215–220
Danoff JR, Moss G, Liabaud B, Geller JA (2013) Total knee arthroplasty considerations in rheumatoid arthritis. Autoimmune Dis 2013:185340
Calisto Perez C, Leon R, Leon F, Ng SL (2012) Rheumatoid arthritis and anemia: the impact of different anti-inflammatory therapies on hemoglobin levels. An observational study. Boletin de la Asociacion Medica de Puerto Rico 104:34–41
Ganna S (2014) The prevalence of anemia in rheumatoid arthritis. Rev Bras Reumatol 54:257–259
Van Manen MD, Nace J, Mont MA (2012) Management of primary knee osteoarthritis and indications for total knee arthroplasty for general practitioners. J Am Osteopath Assoc 112:709–715
Ravi B, Croxford R, Hollands S, Paterson JM, Bogoch E, Kreder H et al (2014) Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis. Arthritis Rheumatol 66:254–263
Momohara S, Inoue E, Ikari K, Kawamura K, Tsukahara S, Mochizuki T et al (2007) Risk factors for total knee arthroplasty in rheumatoid arthritis. Mod Rheumatol 17:476–480
Amin AN, Lenhart G, Princic N, Lin J, Thompson S, Johnston S (2011) Retrospective administrative database study of the time period of venous thromboembolism risk during and following hospitalization for major orthopedic or abdominal surgery in real-world US patients. Hosp Pract (1995) 39:7–17
Cohen ME, Ko CY, Bilimoria KY, Zhou L, Huffman K, Wang X et al (2013) Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus. J Am Coll Surg 217(2):336–346
Cima RR, Lackore KA, Nehring SA, Cassivi SD, Donohue JH, Deschamps C et al (2011) How best to measure surgical quality? Comparison of the Agency for Healthcare Research and Quality Patient Safety Indicators (AHRQ-PSI) and the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) postoperative adverse events at a single institution. Surgery 150:943–949
Affleck G, Tennen H, Keefe FJ, Lefebvre JC, Kashikar-Zuck S, Wright K et al (1999) Everyday life with osteoarthritis or rheumatoid arthritis: independent effects of disease and gender on daily pain, mood, and coping. Pain 83:601–609
Stundner O, Danninger T, Chiu YL, Sun X, Goodman SM, Russell LA et al (2014) Rheumatoid arthritis vs osteoarthritis in patients receiving total knee arthroplasty: perioperative outcomes. J Arthroplasty 29:308–313
Bloxham E, Vagadia V, Scott K, Francis G, Saravanan V, Heycock C et al (2011) Anaemia in rheumatoid arthritis: can we afford to ignore it? Postgrad Med J 87:596–600
Nikolaisen C, Figenschau Y, Nossent JC (2008) Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. J Rheumatol 35:380–386
Leino KA, Palve HK, Tiusanen HT, Tuppurainen TT (2010) The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiol Scand 54:863–870
Sperling JW, Duncan SF, Cofield RH, Schleck CD, Harmsen WS (2005) Incidence and risk factors for blood transfusion in shoulder arthroplasty. J Shoulder Elbow Surg 14:599–601
Kang JH, Hsieh MS, Lin HC (2010) Comparison of treatment outcomes following total knee arthroplasty among patients with rheumatoid arthritis and osteoarthritis: a nationwide population based study. Rheumatology (Oxford) 49:1409–1410
Escalante A, Beardmore TD (1997) Predicting length of stay after hip or knee replacement for rheumatoid arthritis. J Rheumatol 24:146–152
Metsios GS, Stavropoulos-Kalinoglou A, Treharne GJ, Nevill AM, Sandoo A, Panoulas VF et al (2011) Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis. Arthritis Res Ther 13:R108
Elke R, Meier G, Warnke K, Morscher E (1995) Outcome analysis of total knee-replacements in patients with rheumatoid arthritis versus osteoarthritis. Arch Orthop Trauma Surg 114:330–334
Ravi B, Escott B, Shah PS, Jenkinson R, Chahal J, Bogoch E et al (2012) A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum 64:3839–3849
Kerner PJ, Clarke HD, Scuderi GR (2003) Total knee arthroplasty for rheumatoid arthritis. Mod Rheumatol 13:289–292
Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB (1984) Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res 117–26
Wilson MG, Kelley K, Thornhill TS (1990) Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am 72:878–883
Michaud K, Fehringer EV, Garvin K, O'Dell JR, Mikuls TR (2013) Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplasty. Arthritis Res Ther 15:R195
Goodman SM, Figgie M (2013) Lower extremity arthroplasty in patients with inflammatory arthritis: preoperative and perioperative management. J Am Acad Orthop Surg 21:355–363
Funding
This study was performed without external funding.
Disclosures
Julio J. Jauregui, nothing to disclose
Bhaveen H. Kapadia, consultant for SAGE Inc.
Anant Dixit, nothing to disclose
Qais Naziri, nothing to disclose
Jules D. Hip-Flores, nothing to disclose
Steven F. Harwin reports grants and personal fees from SLACK Incorporated. He is a paid consultant for Stryker, Convatec. He receives royalties from Thieme, Inc. and Journal of Knee Surgery and is on the Editorial board of Journal of Arthroplasty, Orthopedics, Journal of Knee Surgery, and Surgical Technology International.
Michael A. Mont receives royalties from Stryker and Microport. He is a paid consultant for Biocomposites; DJ Orthopaedics; Joint Active Systems; Medtronic; Sage Products, Inc.; Stryker; TissueGene; and Microport. He receives research support from DJ Orthopaedics; Joint Active Systems; National Institutes of Health (NIAMS & NICHD); Sage Products, Inc.; Stryker; Tissue Gene; and Microport. He is on the editorial board of the American Journal of Orthopedics; Journal of Arthroplasty; Journal of Bone and Joint Surgery – American; Journal of Knee Surgery; Surgical Techniques International. He is a board member of the American Academy of Orthopaedic Surgeons.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jauregui, J.J., Kapadia, B.H., Dixit, A. et al. Thirty-day complications in rheumatoid patients following total knee arthroplasty. Clin Rheumatol 35, 595–600 (2016). https://doi.org/10.1007/s10067-015-3037-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-015-3037-4